Dr. BT Slingsby, MD, PhD, MPH Chief Executive Officer, Global Health Innovative Technology Fund
BT Slingsby, MD, PhD, MPH, is CEO and Executive Director of the Global Health Innovative Technology (GHIT) Fund, the first public-private partnership fund for global health R&D. Previously, he was Director for Global Access Strategies for Eisai & Co. where he overlooked the research and development of new medicines for portfolios of the emerging markets and developing world. Prior to this, he helped launch numerous start-ups in the U.S. and Japan. Dr. Slingsby is widely-published in both Japanese and American literature and co-authored the first textbook on bioethics in Asia. He holds academic fellow positions at the University of Tokyo and Kyoto University and is also a Forum Member for Public-Private Partnerships for Global Health and Safety at the Institute of Medicine, a Blakemore Fellow, a Scott M Johnson Fellow of the US-Japan Leadership Program, a Murata Prize recipient, and a Gill Scholar, as well as a former professional triathlete and member of the U.S. World Cup Team. Dr Slingsby is a graduate of Brown University and earned his medical and advanced degrees at the George Washington University, Kyoto University, and the University of Tokyo.